• Department of Biophysics, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu 610054, P.R.China;
LIU Yiyao, Email: liuyiyao@uestc.edu.cn
Export PDF Favorites Scan Get Citation

To aggressively proliferate and metastasize, cancer cells are in extreme need of energy supply and nutrients. Therefore, a promising cancer therapy strategy is developed to target its hallmark feature of metabolism. Recent findings revealed the regulatory role of caveolin-1 (Cav-1), a structural protein of caveolae, in cancer metabolism. And low Cav-1 expression in tumor stroma was proved to be a central player of cancer malignant phenotype. Here, we summarized the progressions of studies on Cav-1, mitochondria and cancer metabolism to indicate that the altered metabolism induced by Cav-1 and mitochondria association is a major cause of cancer malignant phenotype.

Citation: JIANG Ying, LI Shun, YANG Hong, WU Chunhui, LIU Yiyao. Caveolin-1 in relation with mitochondria and cancer metabolism—a promising target for cancer therapy. Journal of Biomedical Engineering, 2017, 34(5): 803-806. doi: 10.7507/1001-5515.201703037 Copy

  • Previous Article

    A numerical simulation of dendritic cells migration and induction of T cell specific proliferation during the initiation of skin inflammatory
  • Next Article

    The application of silicon nanowires field-effect transistor biosensor in medicine